Characteristics of each group
| Spontaneous clearance group (n=83) | No spontaneous clearance group (n=322) | Same-day treatment group (n=304) | |
| Age (years) | |||
| Mean (SD) | 30.4 (9.7) | 29.4 (9.9) | 31.3 (10.3) |
| Max | 70.2 | 69.5 | 68.4 |
| Min | 18.1 | 16.1 | 17.1 |
| Gender and type of sexual contact, n (%) | |||
| MSW | 10 (12.0) | 24 (7.5) | 118 (38.8) |
| MSM | 54 (65.1) | 200 (62.1) | 170 (55.9) |
| WSM | 19 (22.9) | 97 (30.1) | 15 (4.93) |
| TWSM | 0 | 1 (0.3) | 0 |
| No data | 0 | 0 | 1 (0.3) |
| Genital discharge | |||
| Female | 8/19 (42.1%) | 39/97 (40.2%) | 7/15 (46.7%) |
| Male | 1/64 (1.6%) | 14/224 (6.3%) | 260/288 (90.3%) |
| Transwoman | – | 0/1 (0%) | – |
| Dysuria | |||
| Female | 1/19 (5.3%) | 26/97 (26.8%) | 6/15 (40.0%) |
| Male | 3/64 (4.7%) | 16/224 (7.1%) | 226/288 (78.4%) |
| Transwoman | – | 0/1 (0%) | – |
| Rectal symptoms | |||
| Female | 2/19 (10.5%) | 3/97 (3.1%) | 2/15 (13.3%) |
| Male | 2/64 (3.1%) | 18/224 (8.0%) | 18/288 (6.3%) |
| Transwoman | – | 0/1 (0%) | – |
| Time interval (days) between pretrial and enrolment test | |||
| Median (IQR) | 10 (7–15) | Missing data | Missing data |
| Range | 2–55 | ||
| Time interval (days) between last sexual intercourse and enrolment test | |||
| Median (IQR) | 14 (6–28) | 14 (7–28) | 7 (5–14) |
| Range | 1–140 | 0–210 | 0–84 |
Rectal symptoms include rectal, discharge, pain, bleeding, tenesmus or constipation.
MSM, man who has sex with men; MSW, man who has sex with women; TWSM, transwoman who has sex with men; WSM, woman who has sex with men.